跳转至内容
Merck

890809P

Avanti

Trehalose monooleate

Avanti Research - A Croda Brand 890809P, powder

别名:

D-(+)-trehalose 6-monooleate

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C30H54O12
分子量:
606.74
分類程式碼代碼:
12352211
NACRES:
NA.25

形狀

powder

包裝

pkg of 1 × 10 mg (890809P-10mg)

製造商/商標名

Avanti Research - A Croda Brand 890809P

運輸包裝

dry ice

儲存溫度

−20°C

SMILES 字串

O[C@H]([C@@H](COC(CCCCCCC/C=C\CCCCCCCC)=O)O[C@H](O[C@@H](O[C@@H]([C@H]([C@@H]1O)O)CO)[C@@H]1O)[C@@H]2O)[C@@H]2O

生化/生理作用

Trehalose monooleate is derived from sugar and fatty acid moieties. It is found to possess anti-aggregation activity. Trehalose monooleate has a sustaining effect against agitation and heat stress in protein. It is considered nonhemolytic and nontoxic. Trehalose monooleate is employed in solid lipid nanoparticles for treating psoriasis.

包裝

5 mL Amber Glass Screw Cap Vial (890809P-10mg)

其他說明

For R&D use only. Not for drug, household, or other uses.

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Nanomaterials for Clinical Applications: Case Studies in Nanomedicines, 17-17 (2020)
Smita S Kale et al.
Molecular pharmaceutics, 13(12), 4082-4093 (2016-10-12)
Protein aggregation is a major problem of therapeutic proteins because aggregation decreases their therapeutic activity and shelf life and induces immunogenicity. Stabilization against aggregation is commonly attained by addition of different excipients like sugars, surfactants, buffers, salts, amino acids, polymers

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门